Circulating Autoantibodies to LGALS3BP: A Novel Biomarker for Cancer

Por Grassadonia, Antonino, Tinari, Nicola, Natoli, Clara, Yahalom, Galit, Iacobelli, Stefano
Publicado em 2013

Meta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancer

Por Belfiglio, Maurizio, Fanizza, Caterina, Tinari, Nicola, Ficorella, Corrado, Iacobelli, Stefano, Natoli, Clara
Publicado em 2011

Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies

Por Grassadonia, Antonino, Cioffi, Pasquale, Simiele, Felice, Iezzi, Laura, Zilli, Marinella, Natoli, Clara
Publicado em 2013

Is the skin a sanctuary for breast cancer cells during treatment with anti-HER2 antibodies?

Por Graziano, Vincenzo, Scognamiglio, Maria Teresa, Zilli, Marinella, Giampietro, Jamara, Vici, Patrizia, Natoli, Clara, Grassadonia, Antonino
Publicado no Cancer Biol Ther (2015)

Beyond evidence-based data: scientific rationale and tumor behavior to drive sequential and personalized therapeutic strategies for the treatment of metastatic renal cell carcinoma

Por Incorvaia, Lorena, Bronte, Giuseppe, Bazan, Viviana, Badalamenti, Giuseppe, Rizzo, Sergio, Pantuso, Gianni, Natoli, Clara, Russo, Antonio
Publicado no Oncotarget (2016)

Effect of Targeted Agents on the Endocrine Response of Breast Cancer in the Neoadjuvant Setting: A Systematic Review

Por Grassadonia, Antonino, Caporale, Marta, Tinari, Nicola, Zilli, Marinella, DeTursi, Michele, Gamucci, Teresa, Vici, Patrizia, Natoli, Clara
Publicado no J Cancer (2015)

Breast cancer follow-up strategies in randomized phase III adjuvant clinical trials: a systematic review

Por Sperduti, Isabella, Vici, Patrizia, Tinari, Nicola, Gamucci, Teresa, De Tursi, Michele, Cortese, Giada, Grassadonia, Antonino, Iacobelli, Stefano, Natoli, Clara
Publicado em 2013

PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis

Por Passiglia, Francesco, Bronte, Giuseppe, Bazan, Viviana, Natoli, Clara, Rizzo, Sergio, Galvano, Antonio, Listì, Angela, Cicero, Giuseppe, Rolfo, Christian, Santini, Daniele, Russo, Antonio
Publicado no Oncotarget (2016)

Breast Cancer “Tailored Follow-up” in Italian Oncology Units: A Web-Based Survey

Por Natoli, Clara, Brocco, Davide, Sperduti, Isabella, Nuzzo, Antonio, Tinari, Nicola, De Tursi, Michele, Grassadonia, Antonino, Mazzilli, Lorenzo, Iacobelli, Stefano, Gamucci, Teresa, Vici, Patrizia
Publicado em 2014

What links BRAF to the heart function? new insights from the cardiotoxicity of BRAF inhibitors in cancer treatment

Por Bronte, Enrico, Bronte, Giuseppe, Novo, Giuseppina, Bronte, Fabrizio, Bavetta, Maria Grazia, Re, Giuseppe Lo, Brancatelli, Giuseppe, Bazan, Viviana, Natoli, Clara, Novo, Salvatore, Russo, Antonio
Publicado no Oncotarget (2015)

Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy

Por Vici, Patrizia, Ercolani, Cristiana, Di Benedetto, Anna, Pizzuti, Laura, Di Lauro, Luigi, Sperati, Francesca, Terrenato, Irene, Gamucci, Teresa, Natoli, Clara, Di Filippo, Franco, Botti, Claudio, Barba, Maddalena, Mottolese, Marcella, De Maria, Ruggero, Maugeri-Saccà, Marcello
Publicado no J Exp Clin Cancer Res (2016)

Long-term outcome of neoadjuvant systemic therapy for locally advanced breast cancer in routine clinical practice

Por Angelucci, Domenico, Tinari, Nicola, Grassadonia, Antonino, Cianchetti, Ettore, Ausili-Cefaro, Giampiero, Iezzi, Laura, Zilli, Marinella, Grossi, Simona, Ursini, Lucia Anna, Scognamiglio, Maria Teresa, Castrilli, Graziella, De Tursi, Michele, Noccioli, Paolo, Cioffi, Pasquale, Iacobelli, Stefano, Natoli, Clara
Publicado em 2012

Long-Term Outcome of Neoadjuvant Endocrine Therapy with Aromatase Inhibitors in Elderly Women with Hormone Receptor-Positive Breast Cancer

Por Grassadonia, Antonino, Di Nicola, Marta, Grossi, Simona, Noccioli, Paolo, Tavoletta, Saveria, Politi, Roberto, Angelucci, Domenico, Marinelli, Camilla, Zilli, Marinella, Ausili Cefaro, Giampiero, Tinari, Nicola, De Tursi, Michele, Iezzi, Laura, Cioffi, Pasquale, Iacobelli, Stefano, Natoli, Clara, Cianchetti, Ettore
Publicado em 2014

The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR statu...

Por Bronte, Giuseppe, Franchina, Tindara, Alù, Massimiliano, Sortino, Giovanni, Celesia, Claudia, Passiglia, Francesco, Savio, Giuseppina, Laudani, Agata, Russo, Alessandro, Picone, Antonio, Rizzo, Sergio, De Tursi, Michele, Gambale, Elisabetta, Bazan, Viviana, Natoli, Clara, Blasi, Livio, Adamo, Vincenzo, Russo, Antonio
Publicado no Oncotarget (2016)

Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer

Por Natoli, Clara, Vici, Patrizia, Sperduti, Isabella, Grassadonia, Antonino, Bisagni, Giancarlo, Tinari, Nicola, Michelotti, Andrea, Zampa, Germano, Gori, Stefania, Moscetti, Luca, De Tursi, Michele, Panebianco, Michele, Mauri, Maria, Ferrarini, Ilaria, Pizzuti, Laura, Ficorella, Corrado, Samaritani, Riccardo, Mentuccia, Lucia, Iacobelli, Stefano, Gamucci, Teresa
Publicado em 2013

The Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy

Por Vici, Patrizia, Mottolese, Marcella, Pizzuti, Laura, Barba, Maddalena, Sperati, Francesca, Terrenato, Irene, Benedetto, Anna Di, Natoli, Clara, Gamucci, Teresa, Angelucci, Domenico, Ramieri, Maria Teresa, Lauro, Luigi Di, Sergi, Domenico, Bartucci, Monica, Dattilo, Rosanna, Pagliuca, Alfredo, Maria, Ruggero De, Maugeri-Saccà, Marcello
Publicado no Oncotarget (2014)

Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer

Por Barba, Maddalena, Vici, Patrizia, Pizzuti, Laura, Di Lauro, Luigi, Sergi, Domenico, Di Benedetto, Anna, Ercolani, Cristiana, Sperati, Francesca, Terrenato, Irene, Botti, Claudio, Mentuccia, Lucia, Iezzi, Laura, Gamucci, Teresa, Natoli, Clara, Vitale, Ilio, Mottolese, Marcella, De Maria, Ruggero, Maugeri-Saccà, Marcello
Publicado no BMC Cancer (2017)

Treatment of Metastatic Colorectal Cancer Patients ≥75 Years Old in Clinical Practice: A Multicenter Analysis

Por Grande, Roberta, Natoli, Clara, Ciancola, Fabrizio, Gemma, Donatello, Pellegrino, Arianna, Pavese, Ida, Garufi, Carlo, Di Lauro, Luigi, Corsi, Domenico, Signorelli, Diego, Sperduti, Isabella, Cortese, Giada, Risi, Emanuela, Morano, Federica, Sergi, Domenico, Signorelli, Carlo, Ruggeri, Enzo Maria, Zampa, Germano, Russano, Marco, Gamucci, Teresa
Publicado no PLoS One (2016)

Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironment

Por Buglioni, Simonetta, Vici, Patrizia, Sergi, Domenico, Pizzuti, Laura, Di Lauro, Luigi, Antoniani, Barbara, Sperati, Francesca, Terrenato, Irene, Carosi, Mariantonia, Gamucci, Teresa, Vincenzoni, Cristina, Mariani, Luciano, Vizza, Enrico, Venuti, Aldo, Sanguineti, Giuseppe, Gadducci, Angiolo, Barba, Maddalena, Natoli, Clara, Vitale, Ilio, Mottolese, Marcella, De Maria, Ruggero, Maugeri-Saccà, Marcello
Publicado no Oncoimmunology (2016)

Neoadjuvant Sequential Docetaxel Followed by High‐Dose Epirubicin in Combination With Cyclophosphamide Administered Concurrently With Trastuzumab. The DECT Trial

Por Pizzuti, Laura, Barba, Maddalena, Giannarelli, Diana, Sergi, Domenico, Botti, Claudio, Marchetti, Paolo, Anzà, Michele, Maugeri‐Saccà, Marcello, Natoli, Clara, Di Filippo, Simona, Catenaro, Teresa, Tomao, Federica, Amodio, Antonella, Carpano, Silvia, Perracchio, Letizia, Mottolese, Marcella, Di Lauro, Luigi, Sanguineti, Giuseppe, Di Benedetto, Anna, Giordano, Antonio, Vici, Patrizia
Publicado no J Cell Physiol (2016)